Showing results (381-390 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|December 19, 2014
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumabGiacomo Allegrini, Luigi Coltelli, Paola Orlandi, et al.Pharmacogenomics|December 19, 2014
Genomic architecture of pharmacological efficacy and adverse eventsAparna Chhibber, Deanna L Kroetz, Kelan G Tantisira, et al.Pharmacogenomics|December 19, 2014
Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factorsDavid Della-Morte, Raffaele Palmirotta, Ashish K Rehni, et al.Pharmacogenomics|August 25, 2017
An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet NetworkNabiha Yusuf, Bertha Hidalgo, Marguerite R Irvin, et al.Pharmacogenomics|August 25, 2017
DNA methylation as a marker of response in rheumatoid arthritisNisha Nair, Anthony G Wilson, Anne BartonPharmacogenomics|October 21, 2017
Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotypeRika Yuliwulandari, Erna Kristin, Kinasih Prayuni, et al.Pharmacogenomics|August 26, 2017
Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectivesCynthia Marie-Claire, Clément Jourdaine, Jean-Pierre Lépine, et al.Pharmacogenomics|May 5, 2016
History repeats itself: the family medication history and pharmacogenomicsThomas R Smith, Elizabeth Kearney, Peter J Hulick, et al.Pharmacogenomics|October 5, 2017
Advancing psychiatric pharmacogenomics using drug development paradigmsRyan M SmithPharmacogenomics|October 5, 2017
Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patientsKonda Kumaraswami, Shiva Krishna Katkam, Amita Aggarwal, et al.Pageof 276